SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Albert David Ltd

BSE: 524075 NSE: ALBERTDAVD ISIN: INE155C01010
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Albert David Ltd belong to?
Albert David Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Albert David Ltd a good quality company?
Albert David Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Albert David Ltd undervalued or overvalued?
Albert David Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Albert David Ltd a good buy now?
Albert David Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Albert David Ltd?
Albert David Ltd revenue growth is -4.6% for FY-2025 , which is below its 5 year CAGR of 1.5% , indicating slower growth.
Q.2 Gross Profit margin of Albert David Ltd?
Albert David Ltd Gross profit margin which is the profit after deduction of direct costs, is 8.7% for FY-2025 , which is below its 5 year median of 16.4% , indicating decreasing margins.
Q.3 Operating Profit Margin of Albert David Ltd?
Albert David Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 1.2% for FY-2025 , which is below its 5 year median of 12.96% indicating decreasing margins.
Q.4 Net Profit Margin of Albert David Ltd?
Albert David Ltd Net Profit Margin is 4.97% for FY-2025 , is below with its 5 year median of 10.59%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 8.7 16.4
Operating Profit Margin 1.2 12.96
Net Profit Margin 4.97 10.59
Q.5 Return on Asset of Albert David Ltd?
Albert David Ltd Return on Asset is 2.8%, which is below its 5 year historical median of 7.33%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Albert David Ltd?
Albert David Ltd Return on equity is 4.44% for FY-2025 , which is below its historical median of 12.24%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Albert David Ltd?
Albert David Ltd Return on capital employed is 6.54% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Albert David Ltd?
Albert David Ltd Cash conversion cycle is 39 days, above its historical median of 32 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.6 0.69
ROE 4.44 12.24
ROCE 6.54 17.1
Cash Conversion Cycle 39 days 32 days
Q.9 Debt to Equity ratio of Albert David Ltd?
Albert David Ltd Debt-to-Equity ratio is 0.03 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Albert David Ltd?
Albert David Ltd Debt to cash flow from operations is -0.35 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Albert David Ltd?
Promoters hold 62.24% of the Albert David Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Albert David Ltd vs industry peers?
Albert David Ltd revenue CAGR is 1.51% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 345.8 137.1
Gross Profit 30.1 15.1
Operating Profit 3 16
Net Profit 17 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.6 0.8
ROE 4.44 8.91
ROCE 6.54 11.59
Cash Conversion Cycle (days) 39.18 76

Valuation & price assessment

Q.1 Stock return of Albert David Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 9.1% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 9.1% 11.7% 7.3% -15.9%
Q.3 Valuation ratios of Albert David Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 43.12 27.89 40.28
Price to Book 1.01 1.11 2.77
Price to Sales 1.28 0.87 2.65
EV to EBITDA 17.05 10.66 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×